Reletter
Artwork for ON THE PEN

ON THE PEN

On The Pen GLP-1 News, Ann Metz

GLP-1 and obesity medicine news.

Platform
Substack
PricingFreemiumPublishesDaily
Issues399SubscribersRead onthepen.substack.com

Curious about how many subscribers ON THE PEN has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 3m+ newsletters.

Chart Rankings

How this newsletter ranks in the official Substack charts.

Latest Issues

Recent posts by this newsletter. Browse the email archive.

LIVE NOW!

Join us!

3 days ago
8
2

WEGOVY Price Drop Exposes a Bigger Problem

A surprising move for Wegovy pricing has Dave thinking we need to pause and remember where we were a year ago. He addresses the growing divide between traditional healthcare and the rise of telehealth, compounding, and alternative access pa...

4 days ago
10
4

GLP-1 Pregnancy Fears vs Reality… The First Real Data Is In

If you’re currently on a GLP-1, or if you’ve been on one long enough to feel your body experience massive changes, you already understand why this conversation matters. These are not casual medications for this community, they are often the...

7 days ago
11
3

TUNE IN NOW: LIVE From Canada!

“Weight & Measure with Mike and Zach is a panel series that brings clinicians, researchers, and experts into direct conversation with lived experience, creating space for honest dialogue about obesity, GLP-1 medications, weight loss, and lo...

8 days ago
6
1

Authors

The writers behind this newsletter.

  • On The Pen GLP-1 News

    On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. On The Pen is a top Substack best-seller.

  • Ann Metz
  • Frequently Asked Questions

    How can I access the email archive for ON THE PEN?

    You can find recent issues that have been published by ON THE PEN on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does ON THE PEN have?

    To see how many people subscribe to ON THE PEN, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in ON THE PEN?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch ON THE PEN as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like ON THE PEN?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact ON THE PEN using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to ON THE PEN?

    Scroll up to where it says Similar Newsletters to see other publications like ON THE PEN. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact ON THE PEN?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.